DPT Meeting: FDA Opening Remarks AGENDA Opening Remarks Janet Woodcock, MD, U.S. Food and Drug Administration Billy Dunn, MD, U.S. Food and Drug Administration 2019 Duchenne Platform Trial Stakeholder Meeting,Conferences & Meetings 5 years ago You may also like 11:23 Antisense Therapeutics 4 years ago Conferences & Meetings,In the Pipeline: Reducing Inflammation 13:19 PTC Therapeutics 4 years ago Approved Therapies,Conferences & Meetings 15:43 Sarepta Therapeutics 4 years ago Approved Therapies,Conferences & Meetings 7:48 What is a Post Market Study? 4 years ago Approved Therapies,Conferences & Meetings 35:48 DPT Meeting: Welcome & Introduction 5 years ago 2019 Duchenne Platform Trial Stakeholder Meeting,Conferences & Meetings 23:02 DPT Meeting: DPT Protocol in Practice 5 years ago 2019 Duchenne Platform Trial Stakeholder Meeting,Conferences & Meetings 43:44 DPT Meeting: Overview of DPT Proposed Protocol 5 years ago 2019 Duchenne Platform Trial Stakeholder Meeting,Conferences & Meetings 49:36 DPT Meeting: Panel 1 – Protocol Objectives & Eligibility 5 years ago 2019 Duchenne Platform Trial Stakeholder Meeting,Conferences & Meetings «1…202122232425»Page 22 of 25
by: Parent Project Muscular Dystrophy
